Treatment.com International (TREIF)
OTHER OTC:TREIF
Holding TREIF?
Track your performance easily

Treatment.com International (TREIF) Stock Price & Analysis

15 Followers

TREIF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

27.36%0.00%0.00%72.64%
27.36% Insiders
0.00% Other Institutional Investors
72.64% Public Companies and
Individual Investors

TREIF FAQ

What was Treatment.com International’s price range in the past 12 months?
Treatment.com International lowest stock price was $0.05 and its highest was $0.91 in the past 12 months.
    What is Treatment.com International’s market cap?
    Currently, no data Available
    When is Treatment.com International’s upcoming earnings report date?
    Treatment.com International’s upcoming earnings report date is May 05, 2025 which is in 227 days.
      How were Treatment.com International’s earnings last quarter?
      Treatment.com International released its earnings results on Aug 29, 2024. The company reported -$0.05 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.05.
        Is Treatment.com International overvalued?
        According to Wall Street analysts Treatment.com International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Treatment.com International pay dividends?
          Treatment.com International does not currently pay dividends.
          What is Treatment.com International’s EPS estimate?
          Treatment.com International’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Treatment.com International have?
          Treatment.com International has 48,293,423 shares outstanding.
            What happened to Treatment.com International’s price movement after its last earnings report?
            Treatment.com International reported an EPS of -$0.05 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.667%.
              Which hedge fund is a major shareholder of Treatment.com International?
              Currently, no hedge funds are holding shares in TREIF
              ---

              Treatment.com International Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              193.47%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              9999.00%
              Trailing 12-Months

              Company Description

              Treatment.com International

              Treatment.com International Inc operates in the mobile health, digital health, telemedicine, and artificial intelligence segments of the global health industry. Its first commercial mobile application is an internally-developed medical intelligence platform, code-named as MERLIN. Multiple pre-production versions of MERLIN are running in multiple Google Cloud Datacenters in the U.S., Canada, and Singapore. The scale and scope of Google Cloud Services provide the company with the data centers and software services needed to provide its diagnostic and treatment services to a global customer base, in multiple languages.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Doximity
              Teladoc
              American Well
              Hims & Hers Health
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis